Eli Lilly and Company
LLY · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5,583 | $5,661 | $2,759 | $4,410 |
| Dep. & Amort. | $470 | $479 | $463 | $485 |
| Deferred Tax | $501 | -$1,069 | -$392 | -$967 |
| Stock-Based Comp. | $151 | $185 | $154 | $142 |
| Change in WC | $5,627 | -$2,263 | -$3,364 | -$2,225 |
| Other Non-Cash | -$3,496 | $94 | $2,046 | $629 |
| Operating Cash Flow | $8,836 | $3,087 | $1,666 | $2,474 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,088 | -$1,697 | -$1,510 | -$1,496 |
| Net Acquisitions | -$549 | $0 | $0 | $0 |
| Inv. Purchases | -$150 | -$171 | -$197 | -$182 |
| Inv. Sales/Matur. | $556 | $204 | $72 | $97 |
| Other Inv. Act. | -$752 | -$171 | -$1,718 | -$340 |
| Investing Cash Flow | -$2,983 | -$1,835 | -$3,352 | -$1,921 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,615 | $825 | $4,612 | $3,042 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$708 | -$692 | -$1,200 | -$2,054 |
| Dividends Paid | -$1,345 | -$1,347 | -$1,346 | -$1,168 |
| Other Fin. Act. | -$30 | -$30 | -$686 | -$46 |
| Financing Cash Flow | $531 | -$1,245 | $1,380 | -$225 |
| Forex Effect | $32 | $276 | $132 | -$429 |
| Net Chg. in Cash | $6,416 | $283 | -$175 | -$101 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,376 | $3,093 | $3,268 | $3,369 |
| End Cash | $9,792 | $3,376 | $3,093 | $3,268 |
| Free Cash Flow | $8,612 | $1,283 | -$1,601 | $727 |